Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 9;15(1):242.
doi: 10.1186/s13256-021-02816-3.

Flumazenil therapy for a gabapentin-induced coma: a case report

M Masciullo  1   2 , F Pichiorri  1 , G Scivoletto  3   4 , C Foti  5 , M Molinari  1
Affiliations
Case Reports

Flumazenil therapy for a gabapentin-induced coma: a case report

M Masciullo et al. J Med Case Rep. .

Abstract

Background: Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-induced coma case, which, to our knowledge, is the second one described in scientific literature.

Case presentation: A 70-year-old Caucasian man was admitted to our neurorehabilitation ward following a fall with cervical trauma that resulted in immediate tetraplegia. During his stay, he suffered from lower limb pain, both neuropathic and due to severe spasticity. Gradual baclofen and gabapentin administration was prescribed, with reduction in both pain and spasticity. One morning, the patient was found unresponsive, with a Glasgow Coma Score of 3. Head computerized tomography, electrocardiogram, electroencephalogram, vital signs, blood tests, breathing, and blood oxygenation were normal. Renal and liver failure were ruled out. Intravenous 0.25 mg of flumazenil (Anexate) was administered, resulting in complete neurocognitive recovery with a Glasgow Coma Score of 15.

Discussion and conclusions: This case report highlights the importance of the individual response to certain pharmacological agents and suggests that further studies need to be conducted both on flumazenil and gabapentin pharmacodynamics to better understand their molecular-receptor activity, and on possible multiple flumazenil mechanisms of action, beyond its classical strict benzodiazepine antagonist action.

Keywords: Baclofen; Case report; Flumazenil; Gabapentin; Neuropathic pain; Spasticity; Spinal cord injury.

PubMed Disclaimer

Conflict of interest statement

Authors do not have any competing interests.

References

    1. Finnerup NB. Neuropathic pain and spasticity: intricate consequences of spinal cord injury. Spinal Cord. 2017;55(12):1046–1050. doi: 10.1038/sc.2017.70. - DOI - PubMed
    1. To TP, Lim TC, Hill ST, et al. Gabapentin for neuropathic pain following spinal cord injury. Spinal Cord. 2002;40(6):282–285. doi: 10.1038/sj.sc.3101300. - DOI - PubMed
    1. Tai Q, Kirshblum S, Chen B, Millis S, Johnston M, DeLisa JA. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med. 2002;25:2, 100–105. 10.1080/10790268.2002.11753609 - PubMed
    1. Gruenthal M, Mueller M, Olson WL, Priebe MM, Sherwood AM, Olson WH. Gabapentin for the treatment of spasticity in patients with spinal cord injury. Spinal Cord. 1997;35(10):686–689. doi: 10.1038/sj.sc.3100481. - DOI - PubMed
    1. Rabchevsky AG, Patel SP, Duale H, Lyttle TS, O’Dell CR, Kitzman PH. Gabapentin for spasticity and autonomic dysreflexia after severe spinal cord injury. Spinal Cord. 2011;49(1):99–105. doi: 10.1038/sc.2010.67. - DOI - PMC - PubMed

Publication types